Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports

被引:1
作者
Chang, Kai-Po [1 ,2 ]
Wang, John [2 ]
Chang, Chi-Chang [3 ,4 ]
Chu, Yen-Wei [5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung 402, Taiwan
[2] China Med Univ Hosp, Dept Pathol, Taichung 404, Taiwan
[3] Chung Shan Med Univ, Sch Med Informat, Taichung 402, Taiwan
[4] Chung Shan Med Univ Hosp, IT Off, Taichung 402, Taiwan
[5] Natl Chung Hsing Univ, Inst Genom & Bioinformat, 145 Xingda Rd, Taichung 402, Taiwan
[6] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan
[7] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan
[8] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 402, Taiwan
[9] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung 402, Taiwan
[10] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan
关键词
PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; AMERICAN SOCIETY; IMMUNOHISTOCHEMISTRY; TEXT; RECOMMENDATIONS; POPULATION; PATHWAY;
D O I
10.1155/2020/2654815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Information about the expression status of hormone receptors such as estrogen receptor (ER), progesterone receptor (PR), and Her-2 is crucial in the management and prognosis of breast cancer. Therefore, the retrieval and analysis of hormone receptor expression characteristics in metastatic breast cancer may be valuable in breast cancer study. Herein, we report a text mining tool based on word/phrase matching that retrieves hormone receptor expression data of regional or distant metastatic breast cancer from pathology reports. It was tested on pathology reports at the China Medical University Hospital from 2013 to 2018. The tool showed specificities of 91.6% and 63.3% for the detection of regional lymph node metastasis and distant metastasis, respectively. Sensitivity in immunohistochemical study result extraction in these cases was 98.6% for distant metastasis and 78.3% for regional lymph node metastasis. Statistical analysis on these retrieved data showed significant difference s in PR and Her-2 expressions between regional and metastatic breast cancer, which is compatible with previous studies. In conclusion, our study shows that metastatic breast cancer hormone receptor expression characteristics can be retrieved by text mining. The algorithm designed in this study may be useful in future studies about text mining in pathology reports.
引用
收藏
页数:7
相关论文
共 40 条
[31]   Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib [J].
Sherrill, Beth ;
Sherif, Bintu ;
Amonkar, Mayur M. ;
Maltzman, Julie ;
O'Rourke, Lisa ;
Johnston, Stephen .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (12) :2245-2252
[32]   Correlation of Ki67 Expression with Hormone Receptors, Human Epidermal Growth Factor Receptor-2 (HER-2) Status, P53 Mutation and Clinicopathological Characteristics in Pathologic Specimens of Breast Cancer Patients [J].
Mirmalek, Seyed Abbas ;
Ghorbani, Maedeh ;
Boushehrinejad, Ala Gholamrezaei ;
Salehi, Masoud ;
Salimi-Tabatabaee, Seyed Alireza ;
Aryan, Hoda .
GALEN MEDICAL JOURNAL, 2016, 5 (02) :90-97
[33]   The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis [J].
Engels, Charla C. ;
de Glas, Nienke A. ;
Sajet, Anita ;
Bastiaannet, Esther ;
Smit, Vincent T. H. B. M. ;
Kuppen, Peter J. K. ;
Seynaeve, Caroline ;
van de Velde, Cornelis J. H. ;
Liefers, Gerrit Jan .
MOLECULAR ONCOLOGY, 2016, 10 (04) :509-516
[34]   ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis [J].
Urso, Loredana ;
Vernaci, Grazia ;
Carlet, Jessica ;
Lo Mele, Marcello ;
Fassan, Matteo ;
Zulato, Elisabetta ;
Faggioni, Giovanni ;
Menichetti, Alice ;
Di Liso, Elisabetta ;
Griguolo, Gaia ;
Falci, Cristina ;
Conte, Pierfranco ;
Indraccolo, Stefano ;
Guarneri, Valentina ;
Dieci, Maria Vittoria .
FRONTIERS IN ONCOLOGY, 2021, 11
[35]   Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors [J].
Werutsky, Gustavo ;
Reinert, Tomas ;
Rosa, Mahira Lopes ;
Barrios, Carlos Henrique .
CLINICAL BREAST CANCER, 2021, 21 (06) :E688-E692
[36]   Prognostic Impact of HER2-Low and HER2-Zero in Resectable Breast Cancer with Different Hormone Receptor Status: A Landmark Analysis of Real-World Data from the National Cancer Center of China [J].
Dai, Qichen ;
Feng, Kexin ;
Liu, Gang ;
Cheng, Han ;
Tong, Xiangyu ;
Wang, Xiang ;
Feng, Lin ;
Wang, Yipeng .
TARGETED ONCOLOGY, 2024, 19 (01) :81-93
[37]   Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial [J].
Cristofanilli, Massimo ;
Turner, Nicholas C. ;
Bondarenko, Igor ;
Ro, Jungsil ;
Im, Seock-Ah ;
Masuda, Norikazu ;
Colleoni, Marco ;
DeMichele, Angela ;
Loi, Sherene ;
Verma, Sunil ;
Iwata, Hiroji ;
Harbeck, Nadia ;
Zhang, Ke ;
Theall, Kathy Puyana ;
Jiang, Yuqiu ;
Bartlett, Cynthia Huang ;
Koehler, Maria ;
Slamon, Dennis .
LANCET ONCOLOGY, 2016, 17 (04) :425-439
[38]   Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysis [J].
Ayyagari, Rajeev ;
Tang, Derek ;
Patterson-Lomba, Oscar ;
Zhou, Zhou ;
Xie, Jipan ;
Chandiwana, David ;
Dalal, Anand A. ;
Niravath, Polly Ann .
CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) :1645-1652
[39]   High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers [J].
Van Acker, Thibaut ;
Buckle, Tessa ;
Van Malderen, Stijn J. M. ;
van Willigen, Danny M. ;
van Unen, Vincent ;
van Leeuwen, Fijs W. B. ;
Vanhaecke, Frank .
ANALYTICA CHIMICA ACTA, 2019, 1074 :43-53
[40]   Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study [J].
Vuylsteke, P. ;
Huizing, M. ;
Petrakova, K. ;
Roylance, R. ;
Laing, R. ;
Chan, S. ;
Abell, F. ;
Gendreau, S. ;
Rooney, I. ;
Apt, D. ;
Zhou, J. ;
Singel, S. ;
Fehrenbacher, L. .
ANNALS OF ONCOLOGY, 2016, 27 (11) :2059-2066